[Personalised medicine in rheumatology]

Tijdschr Psychiatr. 2018;60(3):146-150.
[Article in Dutch]


Background: An important goal in medicine is to provide patients with individualised and personalised treatment. Personalised medicine is making an important contribution.

Aim: To summarise developments in the field of personalised medicine in rheumatology.

Method: We review the results so far and discuss what developments we can expect in the future.

Results: In rheumatology there have been advances in three main areas: 1. therapeutic drug monitoring (measuring medication levels and using the results as a guide for further treatment); 2. the use of biomarkers to determine which drugs should be selected or which should be stopped; 3. involvement of the patient's own observations concerning treatment options.

Conclusion: Personalised medicine is being used increasingly in rheumatology.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Drug Monitoring
  • Humans
  • Patient Participation
  • Precision Medicine*
  • Rheumatology*
  • Treatment Outcome


  • Biomarkers